Worldwide Clinical Trials acquires Catalyst Clinical Research

Worldwide Clinical Trials agreed to acquire Catalyst Clinical Research. Reported deal value: Undisclosed. Status: Pending. Sector: Contract Research Organization (CRO). Target headquarters context: Wilmington, North Carolina, United States.

This page summarizes publicly available information about the transaction as of 2026-02-16. Figures and status may change as filings and press coverage update.

| Press Releases Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research CRO expands oncology , adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer value RESEARCH TRIANGLE PARK , N.C. and NOTTINGHAM, U.K – Worldwide Clinical Trials , a global contract research organization , has completed its acquisition of Catalyst Clinical Research , LCC – a specialized oncology CRO and scalable functional service provider